--- title: Is It Better to Get Cancer Treatment in the Morning? description: "When it comes to a common cancer treatment, appointment timing may in fact be a very big deal," write Christopher Worsham and Anupam Jena. canonical: https://time.com/7306220/cancer-treatment-morning-survival/ author: TIME article:opinion: true article:content_tier: free article:published_time: 2025-07-31T19:23:02.000Z article:modified_time: 2026-10-19T08:09:34.784Z article:section: Ideas og:title: Is It Better to Get Cancer Treatment in the Morning? og:description: "Appointment timing may in fact be a very big deal," write Drs. Christopher Worsham and Anupam Jena. og:url: https://time.com/7306220/cancer-treatment-morning-survival/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blte20691df8e05e17a/6998c8bbf1b082658c6f1925/clock.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2120 og:image:height: 1193 og:image:alt: clock og:type: article twitter:card: summary_large_image twitter:title: Is It Better to Get Cancer Treatment in the Morning? twitter:description: "Appointment timing may in fact be a very big deal," write Drs. Christopher Worsham and Anupam Jena. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blte20691df8e05e17a/6998c8bbf1b082658c6f1925/clock.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Is It Better to Get Cancer Treatment in the Morning? > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=5be52c58-5147-4664-b706-4f4ee6c092b4&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=5be52c58-5147-4664-b706-4f4ee6c092b4&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=5be52c58-5147-4664-b706-4f4ee6c092b4&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=5be52c58-5147-4664-b706-4f4ee6c092b4&cr=time-nl-network-2026q3-v1) ## Video: Is It Better to Get Cancer Treatment in the Morning? [Watch (HLS stream): Is It Better to Get Cancer Treatment in the Morning?](https://cdn.jwplayer.com/manifests/4JzuvH6o.m3u8) (2:45)  _Published 2025-07-31. "Appointment timing may in fact be a very big deal," write Drs. Christopher Worsham and Anupam Jena._ by [Christopher M. Worsham](https://time.com/author/7198766/) and [Anupam Jena](https://time.com/author/anupam-b-jena/) Jul 31, 2025 7:23 PM UTC by [Christopher M. Worsham](https://time.com/author/7198766/) and [Anupam Jena](https://time.com/author/anupam-b-jena/) Jul 31, 2025 7:23 PM UTC If your doctor’s office called to schedule you for a treatment, how would you pick your appointment? Most likely, the scheduler would look at the available time slots, and you’d hear a list of available times—some early in the day, some later. Since you’ll get the same care regardless of when you go, you’d pick the one that best fits your schedule. No big deal, right? Early reports from a [recent study](https://ascopubs.org/doi/10.1200/JCO.2025.43.16%5Fsuppl.8516) suggest that when it comes to a common cancer treatment, appointment timing may in fact be a very big deal. At a June meeting of the American Society of Clinical Oncology (ASCO), researchers from China presented preliminary findings of a study—not yet published in a peer-reviewed journal—where 210 patients receiving treatment for advanced lung cancer were randomized to receive two important treatments either before or after 3 p.m. One of those treatments was standard chemotherapy. The other was an [immunotherapy treatment](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors) designed to boost the ability of the patient’s immune system to kill cancer cells that are growing out of control. After following patients for about 18 months, researchers found that those who had their infusion earlier in the day had improved survival, going months longer without progression of their cancer, compared to patients who had their infusion later in the day. They also saw [evidence of increased immune-system response](https://x.com/StephenVLiu/status/1929538616285335710) in the patients with earlier treatment times. So, why did they think treating cancer patients earlier in the day might improve cancer outcomes? **Read More**: [_The Race to Explain Why More Young Adults Are Getting Cancer_](https://time.com/7213490/why-are-young-people-getting-cancer/) One factor is the body’s [circadian rhythms](https://time.com/5876614/circadian-rhythm-study/). Our immune systems function differently throughout the day, so giving immunotherapy at various times of day could generate different effects, as this new study suggests. In fact, the research builds upon [other studies](https://www.sciencedirect.com/science/article/pii/S2059702923014618) that looked at the timing of this type of immunotherapy in a number of different cancers; they also found improved outcomes among patients treated earlier in the day. For example, in a 2025 [study](https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964%2825%2900051-9/fulltext) analyzing data from 713 patients in France and China with advanced lung cancer, researchers found that patients who received immunotherapy earlier in the day lived longer with cancer. Patients who received their drug infusion before 11:30 a.m. lived an average of 33 months after their first treatment, while those who received treatment after 11:30 a.m. lived an average of about 20 months. This is an astonishing difference, which would seem too large to be possible if similar differences weren’t being reported in the latest randomized trial. It would suggest that something as simple as when in the day a person with cancer receives an immunotherapy could impact survival by as much as one year. To put that into perspective, for some cancer treatments, whether you get the treatment or not—not simply when in the day you might receive it—improves survival by only a couple of months. **Read More**: [_Gun Injuries of All Kinds Go Up During Hunting Season_](https://time.com/7277814/gun-injuries-hunting-season-essay/) Of course, circadian rhythms were only one potential explanation of the differences seen in these previous studies, which were predominantly correlational—meaning they couldn’t establish that early-in-the-day immunotherapy _causes_ people with cancer to live longer. It could have simply been that people who received their cancer drug infusions in the morning were different; they may have been more likely to survive longer from cancer regardless of when in the day they received their infusion. Maybe they were healthier (those with more medical problems might need more time to get to the doctor’s office, making early-in-the-day infusions less likely); wealthier (more resourced patients may do their best to get their treatment early so they have the rest of the day to recover); or generally have better access to care (patients who live in rural areas, where health care access is generally lower, may need to drive several hours to get a drug infusion, making afternoon appointments more common). All of these factors could determine, at least in part, how long someone lives after a diagnosis of cancer. So if any of these things were true, it would be hard to disentangle whether afternoon appointment times lead to lower cancer survival, or if patients with lower expected survival tend to choose afternoon appointment times. That’s why the reports from the ASCO meeting of this randomized trial—which _does_ allow us to get at cause and effect when it comes to treatment timing—are so interesting. It suggests that these prior correlational studies have been onto something. **Read More**: [_Why Do Taxi Drivers Have a Lower Risk of Alzheimer’s?_](https://time.com/7206222/taxi-drivers-alzheimers-disease-christopher-worsham-anupam-jena/) How do we figure out if these early, promising findings are real? Here are a few ideas. First, let’s see how the peer review and publication process for this [new randomized trial](https://www.clinicaltrials.gov/study/NCT05549037) unfolds. Second, this trial should be replicated—and quickly—for lung cancer and other cancers treated with similar immunotherapy. Cancer patients around the world receive immunotherapy every day, and it shouldn’t be difficult to randomize patients to receive treatment at different times of day. Third, following patients in randomized trials takes time, so we should think creatively about how already existing data and “[natural experiments](https://time.com/7275048/shingles-vaccine-dementia-christopher-worsham-anupam-jena/)” can be used to confirm these hypotheses. Researchers might be able to identify instances in which the time of day that patients receive immunotherapy is as good as random (e.g., when heavy traffic, a sick family member, clinic staffing issues, broken equipment, or other random factors lead someone who was previously scheduled for a morning infusion to receive an infusion later that day). We could then account for the issue that people who tend to prefer morning versus afternoon slots might be different in ways that are correlated with their ultimate cancer survival risk. This can allow us to determine whether the time of day someone receives cancer treatment really matters, without having to wait for a trial. At the end of the day, if something as simple as appointment scheduling is enough to significantly prolong life for cancer patients getting immunotherapy, doctors should factor this in when planning treatments. ## Transcript [00:01] So when you're a patient, [00:03] is there a time you like to go to the doctor? [00:06] Of course. I don't ever like to go to the doctor. Uh. [00:09] No. I mean, like a time of day. [00:11] Do you like to go in the morning or the afternoon? [00:13] Oh, I prefer the morning, [00:14] but honestly, I just do whatever is convenient. [00:17] Uh, when I'm going to the doctor. [00:19] Uh, and even when I am the doctor, [00:21] I would just tell patients to come when it's convenient. [00:23] I don't think that there's a particular time of day that I would recommend. [00:27] Yeah. Whether you're a doctor or a patient, [00:29] the priority just seems to be get in the door and get what you need. [00:33] Uh, but what's fascinating is this new study that [00:37] just was presented at the American Society of Clinical Oncology meeting, [00:42] and they found that when a certain type of [00:45] cancer treatment called immunotherapy was given at different times of day. [00:49] So in the morning versus the afternoon, [00:51] it actually impacted cancer patients quite substantially. [00:55] Yeah, I saw that study and it was really shocking to me. [00:59] You know, the way that cancer survives in [01:01] the body is that it's able to evade the immune system. [01:05] And the way that these therapies work is that they unlock [01:08] the body's immune system to try to identify [01:11] that cancer as being foreign and attacking it. [01:13] And, uh, what was surprising about this study is that [01:16] they actually found a survival benefit [01:19] to patients who were randomized to receive [01:21] these therapies in the morning versus later in the day. [01:25] And to me, that again, was, uh, [01:27] something I wouldn't have expected to see. [01:29] I don't know, what did you think about it? [01:31] Yeah, I think then there's this question of what's going [01:33] on here and why did they do this study in the first place? [01:36] And so there is existing research [01:38] suggesting that our immune systems have circadian rhythms, [01:42] just like many other systems in our body do, [01:45] that function differently at different times of day. [01:47] So if you want to test that, [01:49] you do the randomized trial. [01:51] And this is actually built upon other studies that [01:53] just looked at treatments that were given at [01:56] different times of day that also showed these associations between, [02:00] uh, longer survival and morning treatments. [02:04] You know, this the study got a lot of attention. [02:05] It was presented at this international meeting. [02:08] Uh, it hasn't been peer reviewed and published yet. [02:11] So I think next steps are we would want to see what happens to that process. [02:15] Uh, what do other people think about this study? [02:17] And then the second thing is, [02:19] if it is published and the findings seem to be valid, [02:23] it needs to be replicated, [02:24] because if it were the case that something as simple as giving a patient [02:28] with cancer a particular type of therapy in the morning might impact survival, [02:33] uh, that would be really, [02:35] uh, an enormous thing to see. ```json [{"@context":"https://schema.org","@type":"OpinionNewsArticle","@id":"https://time.com/7306220/cancer-treatment-morning-survival/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/7306220/cancer-treatment-morning-survival/"},"headline":"Is It Better to Get Cancer Treatment in the Morning?","datePublished":"2025-07-31T19:23:02.000Z","dateModified":"2026-10-19T08:09:34.784Z","description":"\"Appointment timing may in fact be a very big deal,\" write Drs. Christopher Worsham and Anupam Jena.","url":"https://time.com/7306220/cancer-treatment-morning-survival/","keywords":["health","freelance"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blte20691df8e05e17a/6998c8bbf1b082658c6f1925/clock.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Christopher M. Worsham","jobTitle":null,"url":"https://time.com/author/7198766/"},{"@type":"Person","name":"Anupam Jena","jobTitle":"","url":"https://time.com/author/anupam-b-jena/"}],"articleSection":"Ideas","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blte20691df8e05e17a/6998c8bbf1b082658c6f1925/clock.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"clock","caption":"clock","creditText":"Sunyixun—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/ideas/","name":"Ideas"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/health/","name":"health"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/7306220/cancer-treatment-morning-survival/","name":"Is It Better to Get Cancer Treatment in the Morning?"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Is It Better to Get Cancer Treatment in the Morning?","description":"\"Appointment timing may in fact be a very big deal,\" write Drs. Christopher Worsham and Anupam Jena.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/4JzuvH6o/poster.jpg?width=720","uploadDate":"2025-07-31T16:34:25.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/4JzuvH6o.m3u8","embedUrl":"https://time.com/7306220/cancer-treatment-morning-survival/","duration":"PT2M45S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/7306220/cancer-treatment-morning-survival/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```